A national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis
- PMID: 27757929
- PMCID: PMC5069221
- DOI: 10.1186/s12348-016-0102-3
A national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis
Abstract
Background: The objectives of this study are to assess Canadian ophthalmologists' awareness of established uveitis treatment guidelines and clinical management of uveitis and to assess the frequency of government applications for immunomodulatory therapy (IMT) and identify primary prescribers. A 25-item questionnaire was sent to 759 practicing Canadian ophthalmologists. Six questions assessed demographics including the year of residency completion, training by uveitis specialists during residency, and fellowship training. Five questions assessed application of guidelines to clinical scenarios, and 12 questions assessed referral patterns and success of obtaining coverage for IMT.
Results: Of 144 respondents, 12 (8.3 %) were uveitis specialists; 45.1 % of respondents had uveitis training during residency by a uveitis specialist. Sixty-one percent reported awareness of management guidelines. Recent graduates (2001-2012) referred patients to uveitis specialists (55.3 %) less frequently than earlier graduates. Recent graduates also managed uveitis patients more frequently with corticosteroid injections (15.6 %) than those who graduated before 1980 (9.75 %). The majority (93.6 %) of respondents submitted less than six IMT funding applications for provincial drug coverage yearly, and 5.5 % reported prescribing IMT themselves, rather than referring to other specialists.
Conclusions: Although greater than half of respondents reported awareness of uveitis treatment guidelines, Canadian ophthalmologists' awareness of uveitis treatment guidelines and application of the guidelines to patient care could be improved. Few applications are made for IMT, and the majority of applications are sent by non-ophthalmologists. This suggests the need for further education of ophthalmologist about uveitis treatment guidelines and for more ophthalmologists trained to manage uveitis with IMT.
Keywords: Guidelines; Management; Uveitis.
Figures

Similar articles
-
Evaluating the cost-effectiveness of anterior uveitis investigation by Canadian ophthalmologists.Can J Ophthalmol. 2008 Dec;43(6):652-7. doi: 10.3129/i08-147. Can J Ophthalmol. 2008. PMID: 19020630
-
Anterior uveitis investigation by Canadian ophthalmologists: insights from the Canadian National Uveitis Survey.Can J Ophthalmol. 2006 Oct;41(5):576-83. doi: 10.1016/S0008-4182(06)80026-8. Can J Ophthalmol. 2006. PMID: 17016528
-
The impact of surgical training on the practice of recently graduated ophthalmologists at Riyadh's ophthalmology residency program.Saudi J Ophthalmol. 2019 Oct-Dec;33(4):319-325. doi: 10.1016/j.sjopt.2019.08.001. Epub 2019 Aug 27. Saudi J Ophthalmol. 2019. PMID: 31920440 Free PMC article.
-
Anterior uveitis for the comprehensive ophthalmologist.Can J Ophthalmol. 2025 Apr;60(2):69-78. doi: 10.1016/j.jcjo.2024.07.013. Epub 2024 Aug 8. Can J Ophthalmol. 2025. PMID: 39128830 Review.
-
Ocular leptospirosis: lack of awareness among ophthalmologists and challenges in diagnosis.Curr Opin Ophthalmol. 2022 Nov 1;33(6):532-542. doi: 10.1097/ICU.0000000000000896. Epub 2022 Sep 8. Curr Opin Ophthalmol. 2022. PMID: 36206109 Review.
Cited by
-
Current Landscape of Uveitis Specialists in the United States.J Acad Ophthalmol (2017). 2022 Aug 29;14(2):e187-e192. doi: 10.1055/s-0042-1755581. eCollection 2022 Jul. J Acad Ophthalmol (2017). 2022. PMID: 37388168 Free PMC article.
-
Impact of the COVID-19 Pandemic on Mental Health among Patients with Chronic Ocular Conditions.Vision (Basel). 2023 Jul 11;7(3):49. doi: 10.3390/vision7030049. Vision (Basel). 2023. PMID: 37489328 Free PMC article.
-
Development and validation of a health practitioner survey on ocular allergy.Sci Rep. 2024 Apr 30;14(1):9932. doi: 10.1038/s41598-024-60837-6. Sci Rep. 2024. PMID: 38689009 Free PMC article.
-
Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review.Orphanet J Rare Dis. 2023 Jun 7;18(1):140. doi: 10.1186/s13023-023-02667-9. Orphanet J Rare Dis. 2023. PMID: 37286999 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources